Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02947373 : Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors
PhasePhase 1
AgesMin: 3 Years Max: 18 Years
Eligibility
Inclusion Criteria:

- Children = 3 years and = 18 years of age with a diagnosis of a brain tumor and who do
not require sedation for MR imaging

- Karnofsky = 70 for patients = 16 years of age, and Lansky = 70 for patients < 16 years
of age (See Appendix 1 Performance Status Criteria)

- Patients must not have any significant medical illnesses that in the investigator's
opinion cannot be adequately controlled with appropriate therapy, would compromise the
patient's ability to tolerate the imaging examination or any disease that will obscure
toxicity or dangerously alter response to the imaging agent

- Patients must not be pregnant or breast feeding. Women of childbearing potential are
required to obtain a negative pregnancy test within 14 days of starting treatment.
Effective contraception (men and women) must be used in subjects of child-bearing
potential

- Ability to understand and the willingness of the patient, parent or legal guardian to
provide informed consent

Exclusion Criteria:

- Patients who are not able to comply with study and/or follow-up procedures

- Patients receiving active therapy on an investigational trial at the time of
enrollment should consult with the study chair regarding potential interactions with
other study agents. Patients who are enrolled in a clinical trial but are off- therapy
and in follow up are eligible.

- Patients with history or evidence of cardiac dysfunction
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02947373      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740